MedTrace Logo

Lumenate Observational Vasospasm Interventional Trial (LOVIT)

NCT03511040 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-04-27

No results posted yet for this study

Summary

The LOVIT study is a European prospective, multi-center, open-label, single-arm feasibility trial designed to determine the safety and angiographic effectiveness through 30 days post treatment with Lumenate Intraluminal Device in the treatment of symptomatic vasospasm.

Conditions

  • Vasospasm, Intracranial
  • Subarachnoid Hemorrhage

Interventions

DEVICE

Lumenate Intraluminal Device

Dilation of vasospastic intracranial vessels

Sponsors & Collaborators

  • Neurvana Medical

    lead INDUSTRY

Principal Investigators

  • Prof. Dr. med Anastasios Mpotsaris, MD · Uniklinik RWTH Aachen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-14
Primary Completion
2018-10-30
Completion
2018-12-30

Countries

  • France
  • Germany
  • Hungary
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03511040 on ClinicalTrials.gov